Who’s up for a 2026 PRIME Award?

The 22^nd PRIME Awards has attracted entries from more organisations than ever before, with three pharmaceutical companies topping the short list.

Following a rigorous judging process led by more than 50 industry-leading judges, a total of 81 entries have been shortlisted across 17 categories.

AstraZeneca and Novo Nordisk lead the pack with six nominations across five categories while Novartis has six nominations across four categories.

To see the whole article please log in.

Tiffany Walker

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here